Sustainable earth-abundant bismuth catalytic nanointerfaces using biopolymeric silk fibroin for efficient pollutant reduction. [PDF]
Ali MH, Rahman MA, Hamid AU, Ahmad H.
europepmc +1 more source
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau +8 more
wiley +1 more source
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A <i>DPYD</i> Variant Allele. [PDF]
Heersche N +12 more
europepmc +1 more source
CRUDE PROTEIN IN DIETS FOR fingerlings TAMBAQUI AND ITS REDUCTION WITH AMINO ACID SUPPLEMENTATION
Charlyan de Sousa LIMA
openalex +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
Waste water remediation through ultrafast reduction of organic dyes, nitroaromatics, and nitrofuran antibiotics employing efficient multifunctional rGO/Ni-MOF composites. [PDF]
Tiwari R +7 more
europepmc +1 more source
Self-reduction and fusion reduction of chromite self-reducing pellets
Adolfo Pillihuaman Zambrano
openalex +1 more source
Tackling the “Data Deluge”: a Dimensionality-reduction Approach
Felix J. Herrmann
openalex +2 more sources
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain +10 more
wiley +1 more source
More than a sidekick: GIP signalling and cardiovascular outcomes. [PDF]
Kurt B, Kahles F.
europepmc +1 more source

